S2S is an invitation-only symposium featuring the most innovative therapeutics startup ideas from the world’s top research institutions. Submissions from researchers are reviewed by a senior advisory group composed of experienced biotech investors. Selected presenters work 1-on-1 with advisory group mentors to further refine their concept and prepare a 15-minute presentation. 200+ attendees include entrepreneurs, biotech investors (Angels / VCs), pharma scouts, academic investigators, TTOs, etc.
Submission Guidelines
- Novel, proprietary academic technology in the therapeutics space Less than 4-5 years from the clinic
- Have not received Series A funding
- A legal entity or management team is NOT required
- Must be submitted by the researcher or corresponding TTO
- Do NOT submit confidential information
- More information and submission instructions found on the website
Submissions Deadline: Nov. 15, 2024
S2S is a forum for top scientists from around the world to present their ideas and interact with leading investors and executives in the Boston biotechnology hub. Over 9 years, investigators from institutions including Brown, Carnegie Mellon, Columbia, Harvard, Johns Hopkins, MIT, Northwestern, NYU, Purdue, Scripps, UCLA, University of Iceland, University of Ottawa, University of Pennsylvania, University of Pittsburgh, Yale, and many more have presented their startup ideas at S2S and its precursor, the University Research and Entrepreneurship Symposium (URES).